InspireMD (NSPR) Tops Q3 EPS by 2c

InspireMD (NYSE: NSPR) reported Q3 EPS of ($0.48), $0.02 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $632 thousand versus the consensus estimate of $900 thousand.

For earnings history and earnings-related data on InspireMD (NSPR) click here.

You May Also Be Interested In

• Cerebras CEO says investors misunderstood margin guidance
• TD Cowen cuts Flowserve to Hold, flags guidance reset risk amid Mideast woes
• Crown Crafts (CRWS) Reports Q4 EPS of $0.03